Soliris Helps Treat aHUS Relapse with Kidney Disease During Pandemic

Soliris Helps Treat aHUS Relapse with Kidney Disease During Pandemic

296802

Soliris Helps Treat aHUS Relapse with Kidney Disease During Pandemic

Soliris (eculizumab) is effective for treating relapses in patients with atypical hemolytic uremic syndrome, even in the presence of severe kidney disease, according to a case report. The case study describes a 29-year-old woman with aHUS who experienced a relapse complicated by severe kidney disease, after recovering from COVID-19 pneumonia. She entered remission again with Soliris treatment.  The report, “Importance of eculizumab treatment in recurrence of atypical hemolytic uremic syndrome during the SARS-CoV-2 pandemic,” was…

You must be logged in to read/download the full post.